ArticleNaunyn-Schmiedeberg's archives of pharmacology2025

Tocilizumab alleviated lipopolysaccharide-induced acute lung injury by improving PI3K/AKT pathway.

Junting Weng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.